TokenPost topic

Padcev

1 TokenPost story is tagged Padcev. The newest appear first.

Latest Padcev stories

• European Commission Expands Keytruda-Padcev Use for Cisplatin-Eligible MIBC

  A Phase 3 trial found 24-month event-free survival of 79.4% with the combination, versus 66.2% with gemcitabine-cisplatin.

  Oct 22, 2026, 12:37 AM EDT · Regulation